HBM Healthcare: Cathay Industrial Biotech completes equity financing of $135 mln

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Cathay Industrial Biotech to set foundation for further successful corporate development with financing of $135 million.

Cathay Industrial Biotech announced completion of a significant equity financing of $135 million with Shanxi Lu'an Mining (Group) Co.

Proceeds will be used to expand production capacity of cathay's "long-chain diacid" and "green nylon" business.

HBM Healthcare Investments brings in no additional capital in this financing and owns 10 percent of company with completion of transaction.

Latest stories

Previous article

AMRI acquires Whitehouse Laboratories for $56 Million

Next article

Ascom acquires Italian medical software company UMS

Related stories

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »